NEW YORK (GenomeWeb) – Transgenomic announced today that its shares have been suspended from the Nasdaq. Beginning tomorrow, Feb. 22, the firm's shares will begin trading instead on the OTCQB exchange under the ticker "TBIO."

Earlier this month, the company received written notification from the Nasdaq that it would be delisting Transgenomic's shares as the company no longer met certain continued listing requirements. The firm was required to meet the exchange's minimum share price and shareholder equity requirements on or before Feb. 19 in order to continue trading there.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.